In a recent trial, verapamil showed a trend toward preserving insulin-producing beta cells in patients with Type 1 diabetes but failed to achieve statistical significance.
Once-daily verapamil did not significantly improve C-peptide levels compared with placebo for adults with new-onset type 1 ...
New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback